Relating to the relationship between pharmacists or pharmacies and health benefit plan issuers or pharmacy benefit managers.
CriticalImmediate action required
Medium Cost
Effective:2025-09-01
Enforcing Agencies
Texas Department of Insurance
01
Compliance Analysis
Key implementation requirements and action items for compliance with this legislation
Implementation Timeline
Effective Date: September 1, 2025.
Compliance Deadline:
Contract Provisions: September 1, 2025 (applies to all contracts entered into or renewed on/after this date).
ID Card Standards: January 1, 2026 (for plans issued/renewed on/after this date).
Agency Rulemaking: The Texas Department of Insurance (TDI) is authorized to adopt rules regarding ID card identifiers and contract disclosures. Expect a "regulatory gray zone" regarding the technical specifications of the required online portals until late 2025.
Immediate Action Plan
1.Audit "Evergreen" Clauses: Identify all pharmacy network contracts scheduled for automatic renewal after September 1, 2025. These renewals trigger full compliance with SB1236.
2.Reprogram Audit Software: Update claims processing algorithms to prevent automatic clawbacks of full claim amounts for identified clerical errors.
3.Redraft MSAs: Legal counsel must revise Master Services Agreements to physically include fee schedules and remove unilateral amendment rights.
4.Update ID Card Specs: Coordinate with TPA/printing vendors to ensure group number logic complies with Section 1369.153 by the January 2026 deadline.
Operational Changes Required
Contracts
Eliminate Unilateral Amendments: You must strip provisions allowing you to alter fee schedules or network tiers via simple notice. The law requires affirmative written agreement from the pharmacy for any "adverse material change."
Embed Financial Terms: You may no longer incorporate fee schedules by reference to external documents. All reimbursement rates and calculation methodologies must be explicitly contained within the contract text.
Anti-Steering/Tying: Remove any clauses that condition participation in one network on participation in another; these are now prohibited.
Notice Periods: Redraft notice provisions to align with the statutory 90-day notice for non-adverse changes and the 120-day implementation lag for agreed-upon adverse changes.
Hiring/Training
Audit Teams: Retrain auditors immediately. They must distinguish between "clerical errors" and "fraud/substantive errors." Recouping the full cost of a drug for a clerical typo is now illegal; you may only recoup the dispensing fee.
Provider Relations: Staff must be trained to manage the new "opt-out" process. Silence from a pharmacy regarding a proposed contract change can no longer be interpreted as acceptance.
Reporting & Record-Keeping
Secure Portal: You must maintain a secure, password-protected portal containing all active contracts, addendums, and provider manuals.
Comparison Logic: When proposing non-adverse changes, you must provide a description that allows the pharmacy to compare new terms against old terms within the portal.
Agreement Logs: You must implement a system to archive the specific "written agreement" obtained from pharmacies regarding adverse changes to defend against future breach of contract claims.
Fees & Costs
Fee Ban: You are prohibited from charging application, credentialing, or participation fees *prior* to disclosing all material contract terms and financial provisions.
Recoupment Revenue Loss: Budget for a reduction in audit recoveries due to the ban on recouping drug costs for clerical errors.
Strategic Ambiguities & Considerations
"Clerical" vs. "Substantive" Errors: The statute does not strictly define the boundary between a clerical error (limited recoupment) and a substantive error (full recoupment). TDI rulemaking or litigation will likely define whether repeated clerical errors can be aggregated into a substantive breach.
Digital Consent: The law requires "written agreement." It is currently unclear if a "click-to-accept" button within the provider portal satisfies this statutory requirement or if a digital signature is required.
Materiality Threshold: "Adverse Material Change" includes changes reasonably expected to increase administrative expenses. This is subjective; expect pharmacies to challenge any new reporting requirement as a "material change" requiring mutual consent.
Need Help Understanding Implementation?
Our government affairs experts can walk you through this bill's specific impact on your operations.
Information presented is for general knowledge only and is provided without warranty, express or implied. Consult qualified government affairs professionals and legal counsel before making compliance decisions.
The current Texas Insurance Code regulates the activity of pharmacy benefit managers (PBMs) that operate in Texas. Through market consolidation, just a few PBMs control the vast majority of prescription drug reimbursements in the U.S., and many contend that PBMs have used their market power to force pharmacies to accept "take-it-or-leave-it" contracts with predatory terms.
S.B. 1236 would amend Chapter 1369, Insurance Code, to provide reasonable contract protections for pharmacies and pharmacists in their relationships with PBMs. It would also amend existing statutes to clarify language regarding PBM audits and provide transparency in the applicability of Texas laws to particular contracts and benefit enrollees.
As proposed, S.B. 1236 amends current law relating to the relationship between pharmacists or pharmacies and health benefit plan issuers or pharmacy benefit managers.
RULEMAKING AUTHORITY
Rulemaking authority is expressly granted to the commissioner of insurance in SECTION 1 (Section 1369.153, Insurance Code) of this bill.
SECTION BY SECTION ANALYSIS
SECTION 1. Amends Section 1369.153, Insurance Code, by adding Subsection (e), as follows:
(e) Requires the commissioner of insurance (commissioner) by rule to require a health benefit plan that provides pharmacy benefits to enrollees to include on the front of the identification card of each enrollee a unique identifier that enables a pharmacist or pharmacy to determine when submitting a claim that the enrollee's health benefit plan or pharmacy benefit plan is subject to regulation by the Texas Department of Insurance. Authorizes the commissioner, for purposes of this subsection, to require a unique bank identification number, processor control number, or group number.
SECTION 2. Amends Section 1369.252, Insurance Code, as follows:
Sec. 1369.252. EXCEPTIONS TO APPLICABILITY OF SUBCHAPTER. Deletes existing text providing that Subchapter F (Audits of Pharmacists and Pharmacies) does not apply to an issuer or provider of health benefits under or a pharmacy benefit manager administering pharmacy benefits under a self-funded health benefit plan as defined by the Employee Retirement Income Security Act of 1974 (29 U.S.C. Section 1001 et seq.). Makes nonsubstantive changes.
SECTION 3. Amends the heading to Section 1369.259, Insurance Code, to read as follows:
Sec. 1369.259. LIMITATIONS ON PAYMENT ADJUSTMENTS AND RECOUPMENT; USE OF EXTRAPOLATION PROHIBITED.
SECTION 4. Amends Section 1369.259, Insurance Code, by adding Subsections (a-1) and (e), as follows:
(a-1) Prohibits a health benefit plan issuer or pharmacy benefit manager, as the result of an audit, from denying or reducing a claim payment made to a pharmacist or pharmacy after adjudication of the claim unless the original claim was submitted fraudulently, the original claim payment was incorrect because the pharmacist or pharmacy had already been paid for the pharmacist service, or the pharmacist or pharmacy made a substantive non-clerical or non-recordkeeping error that led to the patient receiving the wrong prescription drug or dosage.
(e) Provides that, except for a claim described by Subsection (a-1), a health benefit plan issuer or pharmacy benefit manager is authorized only to recoup the dispensing fee paid by the health benefit plan issuer or pharmacy benefit manager to the pharmacist or pharmacy associated with the audit claim and is prohibited from recouping from the pharmacist or pharmacy the cost of the drug or any other amount related to the claim.
Sec. 1369.6021. ONLINE ACCESS TO PHARMACY BENEFIT NETWORK CONTRACT. Requires a health benefit plan issuer or pharmacy benefit manager to make available to any pharmacist or pharmacy in the issuer's or manager's pharmacy benefit network access to a secure, online portal through which the pharmacist or pharmacy is authorized to access all pharmacy benefit network contracts between the health benefit plan issuer or pharmacy benefit manager and the pharmacist or pharmacy, including any contract addendums.
Sec. 1369.6022. PHARMACY BENEFIT NETWORK CONTRACT MODIFICATIONS AND ADDENDUMS. (a) Requires a pharmacist or pharmacy to have an opportunity to refuse a proposed modification or addendum to a pharmacy benefit network contract. Prohibits a proposed modification or addendum from taking effect without the signed approval of the pharmacist or pharmacy.
(b) Requires a health benefit plan issuer or pharmacy benefit manager to, not later than the 90th day before the date a proposed modification or addendum to a pharmacy network contract is to take effect, post the proposed modification or addendum to the online portal described by Section 1369.6021 and provide to the pharmacist or pharmacy notice of the proposed modification or addendum by e-mail, including certain information.
(c) Prohibits a pharmacy benefit network contract from incorporating by reference a document not included in a contract or contract attachment, including a provider manual. Requires that all financial terms, including reimbursement rates and methodology, be set forth in the contract.
Sec. 1369.6023. PHARMACY BENEFIT NETWORK CONTRACT DISCLOSURE. Requires that a pharmacy benefit network contract state that the contract is subject to Chapter 1369 (Benefits Related to Prescription Drugs and Devices and Related Services) and any rules adopted by the commissioner under this chapter.
Sec. 1369.6024. PHARMACY BENEFIT NETWORK CONTRACT FEE LIMITATIONS. (a) Prohibits a health benefit plan issuer or pharmacy benefit manager from charging a fee, including an application or participation fee, before providing a pharmacist or pharmacy with the full proposed pharmacy benefit network contract, including any financial terms applicable to the contract and corresponding pharmacy benefit network.
(b) Prohibits a health benefit plan issuer or pharmacy manager from charging a pharmacist or pharmacy already participating in the pharmacy benefit network a fee related to re-credentialing or re-enrollment or a similar fee.
Sec. 1369.6025. PHARMACY BENEFIT NETWORK PARTICIPATION REQUIREMENTS PROHIBITED. Prohibits a health benefit plan issuer or pharmacy benefit plan manager from requiring a pharmacist or pharmacy to participate in a pharmacy benefit network, conditioning a pharmacist's or pharmacy's participation in a pharmacy benefit network on participation in any other pharmacy benefit network, or penalizing a pharmacist or pharmacy for refusing to participate in a pharmacy benefit network.
SECTION 6. Amends Section 1369.605, Insurance Code, as follows:
Sec. 1369.605. NETWORK CONTRACT FEE SCHEDULE. Requires that a pharmacy benefit network contract include a fee schedule, rather than specify or reference a separate fee schedule. Deletes existing text requiring that the fee schedule, unless otherwise available in the contract, be provided electronically in an easily accessible and complete spreadsheet format and, on request, in writing to each contracted pharmacist and pharmacy.
SECTION 7. Repealer: Section 1369.259(d) (relating to prohibiting the inclusion of a dispensing fee amount in the calculation of an overpayment with certain exceptions), Insurance Code.
SECTION 8. (a) Makes application of Section 1369.153, Insurance Code, as amended by this Act, prospective to January 1, 2026.
(b) Makes application of Chapter 1369, Insurance Code, as amended by this Act, prospective.
Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
FROM:
Jerry McGinty, Director, Legislative Budget Board
IN RE:
SB1236 by Hughes (Relating to the relationship between pharmacists or pharmacies and health benefit plan issuers or pharmacy benefit managers.), As Introduced
No significant fiscal implication to the State is anticipated.
It is assumed that any costs associated with the bill could be absorbed using existing resources.
Local Government Impact
No fiscal implication to units of local government is anticipated.
Source Agencies: b > td >
327 Employees Retirement System, 454 Department of Insurance, 529 Health and Human Services Commission, 710 Texas A&M University System Administrative and General Offices, 720 The University of Texas System Administration
LBB Staff: b > td >
JMc, NPe, BFa
Related Legislation
Explore more bills from this author and on related topics
SB1236 fundamentally restructures the contractual relationship between Pharmacy Benefit Managers (PBMs)/Health Issuers and Pharmacies by prohibiting unilateral "adverse material changes" to contracts without written mutual agreement. This legislation voids "amendment-by-notice" practices and severely restricts financial recoupment for clerical errors during audits, shifting significant leverage to network pharmacies. Implementation Timeline Effective Date: September 1, 2025.
Q
Who authored SB1236?
SB1236 was authored by Texas Senator Bryan Hughes during the Regular Session.
Q
When was SB1236 signed into law?
SB1236 was signed into law by Governor Greg Abbott on May 27, 2025.
Q
Which agencies enforce SB1236?
SB1236 is enforced by Texas Department of Insurance.
Q
How urgent is compliance with SB1236?
The compliance urgency for SB1236 is rated as "critical". Businesses and organizations should review the requirements and timeline to ensure timely compliance.
Q
What is the cost impact of SB1236?
The cost impact of SB1236 is estimated as "medium". This may vary based on industry and implementation requirements.
Q
What topics does SB1236 address?
SB1236 addresses topics including electronic information systems, health care providers, insurance, insurance--health & accident and pharmacies & pharmacists.
Legislative data provided by LegiScanLast updated: November 25, 2025
Need Strategic Guidance on This Bill?
Need help with Government Relations, Lobbying, or compliance? JD Key Consulting has the expertise you're looking for.